loading...| Preferred Name |
benazepril |
|
| Synonyms |
|
|
| Definitions |
A condition in which the main influencing factor is benazepril, a benzazepine in which the carboxy group of the 2-amino-4-phenylbutanoic acid moiety of benazeprilat has been converted to the corresponding ethyl ester. Removal of the ester by the liver converts the prodrug back to its active form, benazeprilat. Benazepril is an angiotensin converting enzyme (ACE) inhibitor used in the treatment of hypertension, congestive heart failure, acute myocardial infarction and diabetic nephropathy. |
|
| ID |
http://purl.obolibrary.org/obo/XCO_0000525 |
|
| created_by |
jesmith |
|
| creation_date |
2017-07-18T13:34:04Z |
|
| database_cross_reference |
CHEBI:3011 |
|
| definition |
A condition in which the main influencing factor is benazepril, a benzazepine in which the carboxy group of the 2-amino-4-phenylbutanoic acid moiety of benazeprilat has been converted to the corresponding ethyl ester. Removal of the ester by the liver converts the prodrug back to its active form, benazeprilat. Benazepril is an angiotensin converting enzyme (ACE) inhibitor used in the treatment of hypertension, congestive heart failure, acute myocardial infarction and diabetic nephropathy. |
|
| has_obo_namespace |
experimental_condition_ontology |
|
| id |
XCO:0000525 |
|
| label |
benazepril |
|
| notation |
XCO:0000525 |
|
| prefLabel |
benazepril |
|
| treeView | ||
| subClassOf |